| Source: |
| Type: |
| Autophagy Regulator: – ATG7 is an E1-like enzyme crucial for the autophagy pathway. – It participates in the conjugation systems that drive autophagosome formation (e.g., ATG12–ATG5 and LC3 lipidation systems). • Elevated Expression: – In certain cancers (e.g., pancreatic cancer, some subtypes of breast cancer), ATG7 can be upregulated. – Increased ATG7 expression in some contexts is thought to help tumors survive under metabolic stress by enhancing autophagy. • Reduced Expression or Loss-of-Function: – In other contexts – for instance, in some liver cancers or specific lung cancers – reduced expression or inactivation of ATG7 has been reported. – This reduction might lead to failure of effective autophagy in tumor-suppressive contexts. |
| Medulloblastoma is an aggressive primary brain tumor that arises in the cerebellum of children and young adults. Activation of these three pathways Akt/NF-kB, Shh, and Wnt/b-catenin converge in the upregulation of C-myc, N-myc, and Cyclin D1, three oncoproteins that play key roles in the development of medulloblastomas. High levels of these three oncoproteins were considered to be bad prognosis because they are related to unfavorable therapeutic outcome. |
| 2865- | HNK, | Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma |
| - | in-vitro, | MB, | DAOY | - | vitro+vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:16 Cells:% prod#:% Target#:986 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid